Sufyan Danish

Dr. Sufyan Danish

Department of Computer Science and Engineering, Sejong University, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025 in Information Fusion
Verified
Journal Article
Closed access
Sufyan DanishSufyan Danish
Sufyan Danish
ASAbolghasem Sadeghi-Niaraki
Abolghasem Sadeghi-Niaraki
SKSamee Ullah Khan
Samee Ullah Khan
LDL. Minh Dang
L. Minh Dang
LTLilia Tightiz
Lilia Tightiz
HMHyeonjoon Moon
Hyeonjoon Moon

15 January 2024 in Information
Verified
Journal Article
Open access
PDF file
Sufyan DanishSufyan Danish
Sufyan Danish
AKAsfandyar Khan
Asfandyar Khan
L. Minh DangL. Minh Dang
L. Minh Dang
MAMohammed Alonazi
Mohammed Alonazi
SASultan Alanazi
Sultan Alanazi
Hyeonjoon MoonHyeonjoon Moon
Hyeonjoon Moon
Bioinformatics and genomics are driving a healthcare revolution, particularly in the domain of drug discovery for anticancer peptides (ACPs). The integration of artificial intelligence (AI) has transformed healthcare, enabling personalized and immersive patient care experiences. These advanced technologies, coupled with the power of bioinformatics and genomic data, facilitate groundbreaking developments. The precise prediction of ACPs from complex biological sequences remains an ongoing challenge in the genomic area. Currently, conventional approaches such as chemotherapy, target therapy, radiotherapy, and surgery are widely used for cancer treatment. However, these methods fail to completely eradicate neoplastic cells or cancer stem cells and damage healthy tissues, resulting in morbidity and even mortality. To control such diseases, oncologists and drug designers highly desire to develop new preventive techniques with more efficiency and minor side effects. Therefore, this research provides an optimized computational-based framework for discriminating against ACPs. In addition, the proposed approach intelligently integrates four peptide encoding methods, namely amino acid occurrence analysis (AAOA), dipeptide occurrence analysis (DOA), tripeptide occurrence analysis (TOA), and enhanced pseudo amino acid composition (EPseAAC). To overcome the issue of bias and reduce true error, the synthetic minority oversampling technique (SMOTE) is applied to balance the samples against each class. The empirical results over two datasets, where the accuracy of the proposed model on the benchmark dataset is 97.56% and on the independent dataset is 95.00%, verify the effectiveness of our ensemble learning mechanism and show remarkable performance when compared with state-of-the-art (SOTA) methods. In addition, the application of metaverse technology in healthcare holds promise for transformative innovations, potentially enhancing patient experiences and providing novel solutions in the realm of preventive techniques and patient care.

10 August 2025 in Engineering Applications of Artificial Intelligence
Verified
Journal Article
Closed access
SKSamee Ullah Khan
Samee Ullah Khan
MSMaryam Sultana
Maryam Sultana
Sufyan DanishSufyan Danish
Sufyan Danish
DGDeepak Gupta
Deepak Gupta
NANorah Saleh Alghamdi
Norah Saleh Alghamdi
SASangtae Ahn
Sangtae Ahn

3 September 2024 in European Journal of Agronomy
Verified
Journal Article
Closed access
LDL. Minh Dang
L. Minh Dang
Sufyan DanishSufyan Danish
Sufyan Danish
AKAsma Khan
Asma Khan
NANur Alam
Nur Alam
MFMuhammad Fayaz
Muhammad Fayaz
HMHyeonjoon Moon
Hyeonjoon Moon

30 March 2026 in Sensors
Verified
Journal Article
Open access
PDF file
Muhammad FayazMuhammad Fayaz
Muhammad Fayaz
KHKim Hagsong
Kim Hagsong
Sufyan DanishSufyan Danish
Sufyan Danish
L. Minh DangL. Minh Dang
L. Minh Dang
ASAbolghasem Sadeghi-Niaraki
Abolghasem Sadeghi-Niaraki
Hyeonjoon MoonHyeonjoon Moon
Hyeonjoon Moon
This comprehensive literature review explores the latest advancements in explainable artificial intelligence (XAI) techniques within the field of medical imaging (MI). Over the past decade, machine learning (ML) and deep learning (DL) technologies have made significant strides in healthcare, enabling advancements in tasks such as disease diagnosis, medical image segmentation, and the detection of various medical conditions. However, despite these successes, the widespread adoption of AI-driven tools in clinical practice remains slow, primarily due to the “black-box” nature of many AI models. These models make decisions without transparent reasoning, which poses significant barriers in critical medical and legal environments, where accountability and trust are paramount. This review investigates various XAI methods, focusing on both intrinsic and post-hoc techniques, to evaluate their potential in addressing these challenges. The paper examines how XAI can enhance the transparency of healthcare algorithms, thereby fostering greater trust and confidence among clinicians, patients, and regulators. Key challenges faced by XAI in healthcare, such as limited interpretability, computational complexity, and the absence of standardized evaluation frameworks, are discussed in detail. Furthermore, this work highlights existing gaps in the literature, including the lack of detailed comparative analyses of specific XAI techniques, especially in terms of their mathematical foundations and applicability across diverse medical imaging contexts. In response to these gaps, the paper introduces a new set of standardized evaluation metrics aimed at assessing XAI performance across various medical imaging tasks, such as image segmentation, classification, and diagnosis. The review proposes actionable recommendations for enhancing the effectiveness of XAI in healthcare, with a focus on real-world clinical applications. Unlike previous studies that focus on broader overviews or limited subsets of methods, this work provides a comprehensive comparative analysis of over 18 XAI techniques, emphasizing their strengths, weaknesses, and practical implications. By offering a detailed understanding of how XAI methods can be integrated into clinical workflows, this paper aims to bridge the gap between cutting-edge AI technologies and their practical use in medical settings. Ultimately, the insights provided are valuable for researchers, clinicians, and industry professionals, encouraging the adoption and standardization of XAI practices in clinical environments, thus ensuring the successful integration of transparent, interpretable, and reliable AI systems into healthcare.

29 October 2025 in Applied Soft Computing
Verified
Journal Article
Closed access
YLYanfen Li
Yanfen Li
Muhammad FayazMuhammad Fayaz
Muhammad Fayaz
Sufyan DanishSufyan Danish
Sufyan Danish
Lilia TightizLilia Tightiz
Lilia Tightiz
HWHanxiang Wang
Hanxiang Wang
LDL.MInh Dang
L.MInh Dang